Ani Pharmaceuticals reported $28.82M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.13B 73M
Aerie Pharmaceuticals AERI:US $ 28.15M 3.38M
Ani Pharmaceuticals ANIP:US $ 28.82M 1.89M
Aurora Cannabis Inc ACB:CN 43.17M 3.69M
Canopy Growth Corp WEED:CN C$ 108.85M 1.48M
Depomed DEPO:US $ 10.44M 2.84M
Eli Lilly And LLY:US $ 1.63B 67.2M
Endo International Ordinary Shares ENDP:US 226M 18.48M
Heron Therapeutics HRTX:US $ 32.96M 1.42M
Hikma Pharmaceutical HIK:LN 256M 0
Knight Therapeutics Inc GUD:CN C$ 18.52M 3.77M
Lannett LCI:US $ 17.57M 1.22M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Novartis NVS:US 3.59B 91M
Perrigo Ordinary Shares PRGO:US 282.3M 13M
Teva Pharmaceutical TEVA:IT 849M 30M
Teva Pharmaceutical Industries TEVA:US 849M 30M